Pages that link to "Q42835998"

The following pages link to Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis (Q42835998):

Displaying 31 items.

• Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification (Q22241487) (← links)
• Antibody markers in the diagnosis of inflammatory bowel disease (Q26774452) (← links)
• Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives (Q28085134) (← links)
• Multivariate Modeling Identifies Neutrophil- and Th17-Related Factors as Differential Serum Biomarkers of Chronic Murine Colitis (Q33728144) (← links)
• Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases (Q35748693) (← links)
• Biomarkers in inflammatory bowel disease: current practices and recent advances (Q35840853) (← links)
• IBD serological panels: facts and perspectives (Q36884782) (← links)
• New serological biomarkers of inflammatory bowel disease (Q37262989) (← links)
• Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis (Q37640561) (← links)
• New pathophysiological insights and modern treatment of IBD. (Q37705033) (← links)
• The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease (Q37870433) (← links)
• Serological antibodies in inflammatory bowel disease: a systematic review. (Q37954231) (← links)
• Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis (Q37980405) (← links)
• Current and future role of serogenomics in ulcerative colitis (Q37980742) (← links)
• Is Indeterminate Colitis Determinable? (Q37982300) (← links)
• Systemic antibody responses to gut microbes in health and disease (Q37987289) (← links)
• The Promise and Pitfalls of Serologic Testing in Inflammatory Bowel Disease (Q38002434) (← links)
• Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression? (Q38072225) (← links)
• Serological markers of inflammatory bowel disease (Q38086247) (← links)
• Towards personalized care in IBD. (Q38171924) (← links)
• A contemporary and critical appraisal of 'indeterminate colitis'. (Q38308056) (← links)
• Clinical Utility of Biomarkers in IBD. (Q38539968) (← links)
• Overcoming difficulty in diagnosis and differential diagnosis of Crohn's disease: the potential role of serological and genetic tests (Q38570962) (← links)
• Biological markers in inflammatory bowel disease: practical consideration for clinicians. (Q39904967) (← links)
• Utility of serological markers in inflammatory bowel diseases: gadget or magic? (Q43135089) (← links)
• Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction (Q43886944) (← links)
• Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment. (Q45898977) (← links)
• Role of biomarkers in the diagnosis of inflammatory bowel disease (Q57265426) (← links)
• IgG Antibodies Against Common Gut Bacteria Are More Diagnostic for Crohn's Disease Than IgG Against Mannan or Flagellin (Q57282776) (← links)
• Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis (Q81478266) (← links)
• New-Onset of Crohn's Disease Is Associated with Antistreptolysin O Positive Titers (Q96132954) (← links)